These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21925064)

  • 1. Long-term effects of intermittent Iloprost infusion on pulmonary arterial pressure in connective tissue disease.
    Caravita S; Wu SC; Secchi MB; Dadone V; Bencini C; Pierini S
    Eur J Intern Med; 2011 Oct; 22(5):518-21. PubMed ID: 21925064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases].
    Tian Z; Chen TB; Fang Q; Zeng XF; Liu YT; Li MT; Jiang XC; Gao P; Cheng KA; Wang Q
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2099-102. PubMed ID: 20058611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and long-term effects of inhaled iloprost in portopulmonary hypertension.
    Melgosa MT; Ricci GL; García-Pagan JC; Blanco I; Escribano P; Abraldes JG; Roca J; Bosch J; Barberà JA
    Liver Transpl; 2010 Mar; 16(3):348-56. PubMed ID: 20209595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosolized iloprost in CREST syndrome related pulmonary hypertension.
    Launay D; Hachulla E; Hatron PY; Goullard L; Onimus T; Robin S; Fauchais AL; Queyrel V; Michon-Pasturel U; Hebbar M; Saulnier F; Devulder B
    J Rheumatol; 2001 Oct; 28(10):2252-6. PubMed ID: 11669165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension.
    Langleben D; Orfanos SE; Giovinazzo M; Hirsch A; Baron M; Senécal JL; Armaganidis A; Catravas JD
    Arthritis Rheum; 2008 Apr; 58(4):1156-64. PubMed ID: 18383374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nebulised iloprost on pulmonary function and gas exchange in severe pulmonary hypertension.
    Reichenberger F; Mainwood A; Doughty N; Fineberg A; Morrell NW; Pepke-Zaba J
    Respir Med; 2007 Feb; 101(2):217-22. PubMed ID: 16831539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of iloprost for the treatment of ischaemic digits in paediatric connective tissue diseases.
    Zulian F; Corona F; Gerloni V; Falcini F; Buoncompagni A; Scarazatti M; Martini G; Zacchello F
    Rheumatology (Oxford); 2004 Feb; 43(2):229-33. PubMed ID: 12923288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical analysis of pulmonary arterial hypertension in connective tissue disease].
    Ji YQ; Zhang ZL; Lu WX
    Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):467-71. PubMed ID: 16831323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical analysis of 79 pulmonary arterial hypertension cases from 1892 connective tissue disease patients].
    Lei YX; Zhang X; Cui Y; Dong GF; Luo RQ
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(41):2934-7. PubMed ID: 20137654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review.
    Kato M; Kataoka H; Odani T; Fujieda Y; Otomo K; Oku K; Horita T; Yasuda S; Atsumi T; Ohira H; Tsujino I; Nishimura M; Koike T
    Lupus; 2011 Oct; 20(10):1047-56. PubMed ID: 21676917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of domiciliary intravenous iloprost in idiopathic and connective tissue disease-associated pulmonary arterial hypertension.
    Ramjug S; Hussain N; Hurdman J; Elliot CA; Sabroe I; Armstrong IJ; Billings C; Hamilton N; Kiely DG; Condliffe R
    Respirology; 2017 Feb; 22(2):372-377. PubMed ID: 27651181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The acute effects of inhaled iloprost on hemodynamics and oxygenation in chronic thromboembolic pulmonary hypertension].
    Luo L; Yang YH; Cui N; Xie WM; Zhai ZG; Ma ZH; Wang C
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2103-5. PubMed ID: 20058612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the acute hemodynamic effects of inhaled nitroglycerin and iloprost in patients with pulmonary hypertension undergoing mitral valve surgery.
    Yurtseven N; Karaca P; Uysal G; Ozkul V; Cimen S; Tuygun AK; Yuksek A; Canik S
    Ann Thorac Cardiovasc Surg; 2006 Oct; 12(5):319-23. PubMed ID: 17095973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil for pulmonary arterial hypertension associated with connective tissue disease.
    Badesch DB; Hill NS; Burgess G; Rubin LJ; Barst RJ; Galiè N; Simonneau G;
    J Rheumatol; 2007 Dec; 34(12):2417-22. PubMed ID: 17985403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between iloprost and alprostadil in the treatment of Raynaud's phenomenon.
    Marasini B; Massarotti M; Bottasso B; Coppola R; Del Papa N; Maglione W; Comina DP; Maioli C
    Scand J Rheumatol; 2004; 33(4):253-6. PubMed ID: 15370722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of intravenous iloprost on pulmonary artery hypertension after paediatric congenital heart surgery.
    Onan IS; Ozturk E; Yildiz O; Altin HF; Odemis E; Erek E
    Interact Cardiovasc Thorac Surg; 2016 Feb; 22(2):194-9. PubMed ID: 26604214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery.
    Baysal A; Bilsel S; Bulbul OG; Kayacioglu I; Idiz M; Yekeler I
    Heart Surg Forum; 2006; 9(1):E536-42. PubMed ID: 16387672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of pulmonary arterial hypertension secondary to connective tissue disease in children].
    Xing Y; Song HM; Wu XY; He YY; Wei M
    Zhonghua Er Ke Za Zhi; 2008 Nov; 46(11):822-6. PubMed ID: 19099898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary arterial hypertension complicating connective tissue diseases.
    Hassoun PM
    Semin Respir Crit Care Med; 2009 Aug; 30(4):429-39. PubMed ID: 19634082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and hemodynamic characteristics and possibilities for therapy in patients with severe (functional class IV) pulmonary arterial hypertension associated with diffuse connective tissue diseases].
    Nikolaeva EV; Yudkina NN; Kurmukov IA; Novikova DS; Markelova EI; Volkov AV
    Ter Arkh; 2015; 87(5):24-32. PubMed ID: 26155616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.